Investors Asset Management of Georgia’s Avadel Pharmaceuticals AVDL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.18M Sell
133,075
-6,900
-5% -$61.1K 0.55% 53
2025
Q1
$1.1M Buy
139,975
+19,700
+16% +$154K 0.55% 54
2024
Q4
$1.26M Buy
120,275
+21,200
+21% +$223K 0.62% 49
2024
Q3
$1.3M Buy
99,075
+9,600
+11% +$126K 0.61% 49
2024
Q2
$1.26M Buy
89,475
+2,100
+2% +$29.5K 0.61% 52
2024
Q1
$1.48M Sell
87,375
-19,100
-18% -$323K 0.69% 46
2023
Q4
$1.5M Buy
+106,475
New +$1.5M 0.76% 43
2023
Q3
Sell
-93,975
Closed -$1.55M 165
2023
Q2
$1.55M Sell
93,975
-36,831
-28% -$607K 0.8% 33
2023
Q1
$1.2M Sell
130,806
-7,500
-5% -$68.7K 0.64% 47
2022
Q4
$990K Sell
138,306
-2,269
-2% -$16.2K 0.52% 58
2022
Q3
$704K Buy
140,575
+700
+0.5% +$3.51K 0.36% 72
2022
Q2
$341K Buy
139,875
+46,500
+50% +$113K 0.18% 114
2022
Q1
$638K Buy
93,375
+6,700
+8% +$45.8K 0.32% 85
2021
Q4
$700K Buy
86,675
+16,400
+23% +$132K 0.33% 78
2021
Q3
$689K Buy
70,275
+7,500
+12% +$73.5K 0.36% 73
2021
Q2
$422K Buy
62,775
+7,150
+13% +$48.1K 0.23% 105
2021
Q1
$503K Buy
+55,625
New +$503K 0.29% 90
2020
Q4
Sell
-53,325
Closed -$269K 142
2020
Q3
$269K Buy
53,325
+17,125
+47% +$86.4K 0.18% 110
2020
Q2
$292K Buy
36,200
+3,600
+11% +$29K 0.2% 103
2020
Q1
$259K Sell
32,600
-3,500
-10% -$27.8K 0.21% 101
2019
Q4
$273K Hold
36,100
0.17% 128
2019
Q3
$150K Buy
36,100
+3,000
+9% +$12.5K 0.1% 144
2019
Q2
$96K Sell
33,100
-1,650
-5% -$4.79K 0.06% 144
2019
Q1
$50K Buy
34,750
+500
+1% +$719 0.03% 141
2018
Q4
$88K Buy
34,250
+2,000
+6% +$5.14K 0.07% 138
2018
Q3
$142K Buy
32,250
+8,800
+38% +$38.7K 0.1% 144
2018
Q2
$144K Buy
23,450
+8,400
+56% +$51.6K 0.11% 139
2018
Q1
$110K Buy
15,050
+4,700
+45% +$34.4K 0.08% 144
2017
Q4
$85K Sell
10,350
-700
-6% -$5.75K 0.06% 144
2017
Q3
$116K Hold
11,050
0.09% 140
2017
Q2
$122K Hold
11,050
0.08% 139
2017
Q1
$107K Buy
+11,050
New +$107K 0.07% 144